Detalhe da pesquisa
1.
Therapeutic drug monitoring of vedolizumab therapy in inflammatory bowel disease.
J Gastroenterol Hepatol
; 39(6): 1088-1098, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380724
2.
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia.
Scand J Gastroenterol
; 58(1): 25-33, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35996928
3.
Trajectories of health-related quality of life and fatigue during vedolizumab therapy in inflammatory bowel disease.
J Gastroenterol Hepatol
; 38(4): 574-583, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36582016
4.
Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease.
Clin Gastroenterol Hepatol
; 20(3): 559-568.e5, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33371995
5.
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.
Ther Drug Monit
; 44(2): 290-300, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34387220
6.
A systematic monitoring approach to biologic therapies in inflammatory bowel disease: patients' and physicians' preferences and adherence.
Scand J Gastroenterol
; 57(3): 274-281, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779308
7.
Fatigue is a systemic extraintestinal disease manifestation largely independent of disease activity, chronicity, and nutritional deficiencies in inflammatory bowel disease on biologics.
Scand J Gastroenterol
; 57(9): 1051-1057, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35412932
8.
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Scand J Gastroenterol
; 55(8): 884-890, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631131
9.
Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure.
Ther Drug Monit
; 41(2): 235-242, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883516
10.
Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study.
Scand J Gastroenterol
; 53(8): 930-937, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987951
11.
Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
Dig Dis Sci
; 63(6): 1583-1591, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29564674
12.
Reply.
Clin Gastroenterol Hepatol
; 20(4): e912-e913, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33965577
13.
Herpes Zoster Meningoencephalitis: A Novel, Rare, Potentially Fatal Side Effect to Tofacitinib.
Am J Gastroenterol
; 117(1): 195-196, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983891
14.
Confocal laser endomicroscopy in ulcerative colitis: a longitudinal study of endomicroscopic changes and response to medical therapy (with videos).
Gastrointest Endosc
; 84(2): 279-286.e1, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945556
15.
Confocal laser endomicroscopy: a novel method for prediction of relapse in Crohn's disease.
Endoscopy
; 48(4): 364-72, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26583952
16.
Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel Disease.
J Clin Gastroenterol
; 50(6): 483-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26166141
17.
Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy.
Am J Gastroenterol
; 110(11): 1526-32, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26032156
18.
Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients.
Int J Med Microbiol
; 305(8): 925-36, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26522075
19.
Clinical outcome of adalimumab therapy in patients with ulcerative colitis previously treated with infliximab: a Danish single-center cohort study.
Scand J Gastroenterol
; 50(8): 1018-24, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25861832
20.
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
Dig Dis Sci
; 60(9): 2762-70, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25673037